Navigation Links
Flexpoint on Target for Release of Disposable Directional ColonoScope with Haemoband Surgical, LTD.
Date:9/17/2013

DRAPER, Utah, Sept. 17, 2013 /PRNewswire/ -- Flexpoint Sensor Systems, Inc. (http://www.flexpoint.com/), today announced they expect to complete both Phase Two and Phase Three of development of the colonoscope application during the remainder of 2013. The company will receive milestone cash payments for each stage of the development process.

Phase Two will be finished upon delivery of the revised electronic and sensor package.  Phase Two completion will include working prototypes to be used for lab testing.  The final phase will include several working colonoscope devices and the associated electronics in preparation for successful medical trails and gathering the information necessary for completion of the required governmental certifications.  Phase Two is nearing conclusion. The completed systems should be delivered for Phase Two and the commencement of Phase Three should begin by the end of September.  

There are about 5 million procedures per year in the US alone with growth expected as population ages in industrial nations. 

"The product has superior accuracy and resolution over traditional sensor designs and is disposable after one use.  At full production this is the most promising consistent revenue stream of our products.  Phase Two has included refinements to the system and actual testing of the completed systems.  After successful meetings between the two companies last week, it became clear that we are on track to deliver the innovative, inexpensive, accurate product that Haemoband Surgical requires.  We are pleased with the results and look forward to delivering the sensor, electronics and hand-held monitors to Haemoband by the end of the month.   It is anticipated, upon approvals and certifications of the product, that we will enter into a long term Manufacturing and Supply agreement with Haemoband.  This product should be widely available during the first half of 2014," stated Flexpoint CEO Clark Mower.

About Haemoband Surgical Ltd
Haemoband Surgical was founded in 2005 in Belfast, Northern Ireland, by Essam Ghareeb and Colin Foster. Mr Ghareeb's profession as a lower gastrointestinal surgeon, and Mr Foster's experiences in the medical marketplace and in bringing products to a global market, led to the design, development and launch of Haemoband, the first automatic multi-action, pre-loaded, disposable ligator onto the global market.  Haemoband Surgical works to the highest levels of quality possible and has achieved many quality certifications.  The most recent of which is a FDA 510k clearance. For further information please visit www.haemoband.com

About Flexpoint:
Flexpoint Sensor Systems, Inc. (FLXT), (http://www.flexpoint.com/) is an innovative technology firm specializing in developing products that feature the Company's patented Bend Sensor® and related technology.  The Bend Sensor® is a groundbreaking sensing solution that is revolutionizing applications in the automotive, safety, medical and industrial industries. The Bend Sensor's single-layer, thin film construction cuts costs and mechanical bulk while introducing a range of functions and stylistic design possibilities that have never before been available in sensing technology. Flexpoint's technology and expertise have been recognized by the world's elite business and academic innovators for over 17 years. The company is setting a new standard for sensing solutions in the "smart" age of technology. 

Forward-Looking Statements
This press release contains certain forward-looking statements.  Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Contact Information:
Flexpoint Sensor Systems
Clark Mower, President
801-568-5111

Brokers and Analysts:
Chesapeake Group
410-825-3930

 


'/>"/>
SOURCE Flexpoint Sensor Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexpoint Announces Universal Settlement Involving the Medical Bed and Related Technologies
2. Flexpoint Announces Progress on the Medical Bed and Related Technologies
3. Sales of Flexpoint Sensors Increases Substantially in January
4. Flexpoint Completes Certification for Pressure Relief Device
5. Flexpoint to Develop New Sensor Type
6. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
7. New Drug that Delivers Targeted Radiation Minimizes Pain and May Extend Prostate Cancer Survival
8. arGEN-X Identifies Potent Antibody Antagonists against Complex Chronic Pain Target Nav1.7
9. Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease
10. GUARDaHEART to Host Exclusive Event focused on Targeting Heart Disease in Celebration of the World Heart Day Mission
11. MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
Breaking Medicine News(10 mins):